Figure Gallery

Expression Pattern Search Results for DsRed2

(245 figures with expression from 143 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Samsa et al., 2015	Fig. 1	s843Tg; vc6Tg s843Tg; vc6Tg + MO1-tnnt2a	control chemical treatment: blebbistatin	Protruding-mouth	atrium cardiac muscle cell cardiac muscle cell cardiac ventricle cardiac muscle cell
	Fig. 4	s843Tg; vc6Tg s843Tg; vc6Tg + MO2-notch1b s843Tg; vc6Tg + MO5-efnb2a	control	Protruding-mouth	cardiac muscle cell
	Fig. 6	s940Tg; vc6Tg s940Tg; vc6Tg + MO1-ift88 + MO3-ift88	control	Long-pec to Protruding-mouth	cardiac muscle cell
	Fig. 3	s940Tg; vc6Tg	control	Prim-5 to Day 5	cardiac muscle cell
	Fig. 2	um14Tg; vc6Tg um14Tg; vc6Tg + MO1-tnnt2a um14Tg; vc6Tg + MO2-notch1b	control	Long-pec	cardiac muscle cell
Wang et al., 2015	Fig. 2	nz50Tg (AB) mpx^sm681/sm681; nz50Tg (AB)	control	Long-pec	neutrophil
	Fig. 4	nz50Tg (AB) mpx^sm681/sm681; nz50Tg (AB)	fungal treatment: Candida albicans	Long-pec to Day 4	neutrophil
Wang et al., 2015	Fig. 3	hkz04tTg; nz50Tg hkz04tTg; nz50Tg + MO1-irf4a	control	Pec-fin	neutrophil thymus primordium neutrophil
	Fig. 5	nz50Tg; zf169Tg irf4a^ioz2Tg; nz50Tg nz50Tg; zf169Tg + MO1-irf4a	control	Long-pec to Protruding-mouth	hematopoietic system hematopoietic system hematopoietic cell
Wu et al., 2015	Fig. 1	f1Tg; la116Tg tln1^f102k/f102k; f2Tg; la116Tg	standard conditions	Long-pec	myocardium nucleus
Yan et al., 2015	Fig. 3	nz50Tg nz50Tg + MO1-irf8 nz50Tg + MO3-csf3r gz32Tg; nz50Tg gz32Tg; nz50Tg + MO1-irf8 gz32Tg; nz50Tg + MO3-csf3r	chemical treatment: doxycycline monohydrate	Day 6	neutrophil
	Fig. 1	nz50Tg gz32Tg; nz50Tg	chemical treatment: doxycycline monohydrate	Protruding-mouth to Days 7-13	neutrophil
	Fig. 4	nz50Tg gz32Tg; nz50Tg	chemical treatment: doxycycline monohydrate	Days 7-13	neutrophil
	Fig. 8	gz32Tg; nz50Tg	chemical treatment: doxycycline monohydrate, chemical treatment: SB 431542 chemical treatment: doxycycline monohydrate	Days 7-13	neutrophil
	Fig. S1	nz50Tg nz50Tg + MO1-irf8 nz50Tg + MO3-csf3r	standard conditions control	Day 6	neutrophil
Al Oustah et al., 2014	Fig. 1	vu17Tg; vu19Tg vu17Tg; vu19Tg + MO5-sulf1	standard conditions control	Protruding-mouth	spinal cord oligodendrocyte
Alcaraz-Pérez et al., 2014	Fig. 2	nz50Tg nz50Tg + MO2-linc-tr	standard conditions	Protruding-mouth	neutrophil
Carroll et al., 2014	Fig. 7	pd27Tg; zf255Tg pd27Tg; zf169Tg	control chemical treatment by environment: 17beta-estradiol chemical treatment by environment: estrogen receptor antagonist	Prim-25	dorsal aorta
de Oliveira et al., 2014	Fig. 2	nz50Tg nz50Tg + MO1-duox + MO4-tp53 nz50Tg + MO4-tp53	amputation: caudal fin, chemical treatment: dibenziodolium chloride amputation: caudal fin	Protruding-mouth	neutrophil
	Fig. 1	nz50Tg	amputation: caudal fin, chemical treatment: adenosine phosphate amputation: caudal fin, chemical treatment: tetrasodium 5'-phosphonatopyridoxal-6-azobenzene-2,4-disulfonate amputation: caudal fin, chemical treatment: suramin sodium amputation: caudal fin, chemical treatment: U-73122 amputation: caudal fin, chemical treatment: thapsigargin amputation: caudal fin	Protruding-mouth	neutrophil
deCarvalho et al., 2014	Fig. 4	rw0110bTg; rw0135Tg; rw0143aTg	standard conditions	Day 4	dorsal habenular nucleus
	Fig. 5	rw0110bTg; rw0135Tg; rw0143aTg	standard conditions	Day 4 to Adult	interpeduncular nucleus tegmentum
Elks et al., 2014	Fig. 1	nz50Tg	standard conditions bacterial treatment	Long-pec	neutrophil
Gutierrez et al., 2014	Fig. 1	mitfa^w2/w2; zdf7Tg/zdf7Tg mitfa^w2/w2; zdf14Tg/+; zdf7Tg/+	standard conditions chemical treatment: dimethyl sulfoxide, chemical treatment: pharmaceutical	Days 7-13 to Adult	pro-T cell thymus
Hall et al., 2014	Fig. 6	nz117Tg; nz25Tg	amputation: caudal fin	Long-pec to Pec-fin	somite